Skip to main content
logo
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
1,641.00
-49.50 (-2.93%)
Aug 1, 2025, 3:30 PM JST

Accolade Revenue

In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B JPY, down -3.14%. Ono Pharmaceutical had revenue of 112.31B in the quarter ending March 31, 2025, a decrease of -0.41%.

Revenue
486.87B
Revenue Growth
-3.14%
P/S Ratio
1.58
Revenue / Employee
113.57M
Employees
4,287
Market Cap
770.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.22B
Daiichi Sankyo Company1,886.26B
HOYA Corporation866.03B
Takeda Pharmaceutical Company4,480.25B
Otsuka Holdings2,393.18B
Terumo1,036.17B
Astellas Pharma1,944.99B
Shionogi &440.50B
Revenue Rankings

Ono Pharmaceutical News

More News